Alex Sirois

Alex Sirois

InvestorPlace Contributor

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Insiders Are Betting on GameStop Stock, Which Makes Plenty of Sense

By Alex Sirois, InvestorPlace Contributor

A GameStop revival remains an unlikely story to many at this point. That doesn't mean GME stock won't provide returns though.

Ripple Price Prediction: $1 Is Within Striking Distance

By Alex Sirois, InvestorPlace Contributor

Ripple continues to look to win its SEC lawsuit on recent news and the lawsuit could be nearing its end. $1 may be near.

What Volatility in Novavax Means for Investors

By Alex Sirois, InvestorPlace Contributor

Novavax continues to await FDA news about its Covid-19 vaccine, but that's not everything that drives the price of NVAX stock.

Rivian’s New CSO Could Help Revive RIVN Stock In the Long Run

By Alex Sirois, InvestorPlace Contributor

Downtrodden RIVN stock needs a shot in the arm and Anisa Kamadoli Costa, a newly appointed CSO by Rivian, could be the trick.

Don’t Buy CLOV Stock Ahead of Earnings Report

By Alex Sirois, InvestorPlace Contributor

CLOV stock doesn't look good because revenue increases don't trump its greater issues. Don't get in ahead of Q1 earnings.

Load More